About VDyne
COMPANY OVERVIEW
VDyne is a clinical-stage medical device company dedicated to developing transcatheter valve solutions for the treatment of debilitating and life-threatening Tricuspid Regurgitation (TR).
Our proprietary technology is – quite literally – turning twenty years of transcatheter valve delivery on its side. Our minimally invasive side-delivery technology enables physicians to treat more TR patients than ever before.
VDyne is undertaking multiple clinical studies in the United States, Europe, and Australia.
VDyne is based in Minneapolis, Minnesota.
VDYNE LEADERSHIP TEAM
Bob Vidlund
Chief Operating Officer
Lauren Farrell
Chief Financial Officer
Vinny Podichetty, MD
VP - Clinical Affairs
Erik Kari
Quality Assurance
Rick Theisen
Operations
Laura Moffett
Clinical & Regulatory
Neela Saikrishnan
Research and Development
Scott Kramer
Research and Development
Hagen Gollnick
Therapy Development - EU
Bassam Alansari
Therapy Development - US
VDYNE BOARD OF DIRECTORS
David McIntyre
Chairman
Lucian Lozonschi, MD
Director
Greg Pearl, MD
Director
Jean-Raymond Boulle II
Director
The VDyne Valve System is an investigational product only that is presently undertaking human (clinical) feasibility studies. The VDyne System is not approved for sale or use for the treatment of any health condition.